Ablynx gets FDA green light for CabliviAblynx's Cablivi is the first therapy for the treatment of adult patients with a rare blood clotting disorder. IQVIA launches IQVIA BiotechIQVIA Biotech is a new drug development solutions suite for small biotech and biopharma companies. FDA approves new Alimta indication The FDA's approval of Lilly’s Alimta in combination with Merck's Keytruda, and platinum chemotherapy, is a breakthrough for patients with lung cancer. Mayne Pharma launches Tolsura Mayne's launch of Tolsura provides a new treatment to fight life-threatening fungal infections. FDA approves new Imbruvica indication The Food and Drug Administration’s approval of Imbruvica in combination with obinutuzumab helps reduce the need for chemotherapy. Upsher-Smith celebrates its centennial As it marks a century in business, Upsher-Smith said its plans include diversifying and expanding its portfolio. Dr. Reddy’s gets FDA nod for Tosymra The Food and Drug Administration’s approval of Dr. Reddy's Tosymra provides a nasal spray for the acute treatment of migraine. Genentech appoints new CEO Genentech has named Alexander Hardy its CEO effective March 1, succeeding Bill Anderson. Aurobindo to acquire Spectrum’s oncology injectables portfolio Aurobindo is entering the branded oncology injectable space via an acquisition from Spectrum Pharmaceuticals. FDA approves new Cabometyx indication FDA's approval of a new Cabometyx indication provides a treatment for patients with liver cancer. First Previous 41 42 43 44 45 Next Last
